Al Jalila Foundation's annual Ramadan campaign kicks off in UAE - GulfToday

Al Jalila Foundation's Ramadan campaign kicks off in UAE

jalila

The campaign has creative fundraising activities under the slogan "Your gift, their smile" to spread hope and healing to sick children.

DUBAI: Al Jalila Foundation, a global philanthropic healthcare organisation dedicated to transforming lives, today announced the launch of the third edition of the annual Ramadan campaign ‘basma’, smile in Arabic, in partnership with hospitality, leisure, and retail outlets across the UAE.

Al Jalila Foundation works with the basma partners to engage their patrons during the month of giving through creative fundraising activities under the slogan "Your gift, their smile" to spread hope and healing to sick children.

In the past the month-long charity campaign has brought together hundreds of partners who have raised over Dhs2 million, through the support of patrons and customers, to provide life-saving treatment and medical care to children in need.

In line with the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President, Prime Minister and Ruler of Dubai, to create hope, life, and happiness for everyone in the UAE, Al Jalila Foundation believes that health is the cornerstone to happiness and every child deserves the opportunity to grow up healthy.


Al Jalila Foundation works closely with healthcare partners to develop special treatment programmes that meet the needs of patients who are unable to afford quality treatment. Farah, happiness in Arabic, is the foundation’s paediatric treatment programme which has helped 254 children in the UAE: from life-saving heart surgeries to treatment of childhood cancers, cochlear implants and prosthetic limbs, all have been given a fresh start in life after receiving special care by some of the best medical providers and physicians in the region.

In 2018, Al Jalila Foundation sponsored the first kidney transplant in Dubai as part of its efforts to transform the lives of children and fund cutting-edge treatment to improve patients’ lives.

WAM